The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy

por Min, Byung-Hoon, Bae, Jeong Mo, Lee, Eui Jin, Yu, Hong Suk, Kim, Young-Ho, Chang, Dong Kyung, Kim, Hee Cheol, Park, Cheol Keun, Lee, Suk-Hee, Kim, Kyoung-Mee, Kang, Gyeong Hoon
Publicado 2011